3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
2
Anatomic Stage II Breast Cancer AJCC v8
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Multiple Myeloma
1
Melanoma
1
Malignant Solid Neoplasm
1
Lymphoma
1
Lung Neoplasms
1
Hematologic Neoplasms
1
Glioma
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
Azacitidine
12
Cyclophosphamide
10
venetoclax
8
fludarabine phosphate
7
fludarabine
7
Whole-Body Irradiation
7
Biopsy
7
Specimen Handling
6
Mycophenolic Acid
6
Injections
6
Decitabine
6
Tacrolimus
5
Cytarabine
5
Busulfan
5
decitabine and cedazuridine drug combination
4
Stem Cell Transplantation
4
Peripheral Blood Stem Cell Transplantation
4
Cyclosporine
4
cedazuridine
3
X-Rays
3
Granulocyte Colony-Stimulating Factor
3
Filgrastim
3
olutasidenib
2
Vorinostat
2
Sirolimus
2
Rituximab
2
Melphalan
2
Magnetic Resonance Spectroscopy
2
Lenalidomide
2
Idarubicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelomonocytic, Chronic
×
2C4 antibody
×
90 days
×
Clear all
No trials found.